LEADER 00679nam0-22002651i-450-
001 990003604840403321
005 20001010
035   $a000360484
035   $aFED01000360484
035   $a(Aleph)000360484FED01
035   $a000360484
100   $a20000920d1954----km-y0itay50------ba
101 0 $aita
105   $ay-------001yy
200 1 $aEdward Gilbon.$fG. Giarrizzo
210   $aNapoli$cs.e.$d1954
700  1$aGiarrizzo,$bGiuseppe$f<1927- >$0125269
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990003604840403321
952   $aSE 08.01.01-$b05544$fDECSE
959   $aDECSE
996   $aEdward Gilbon$9494745
997   $aUNINA
DB    $aING01

LEADER 01135nam0-2200373 --450 
001 9910648900403321
005 20240311121039.0
010   $a0121820122
100   $a20230309d1985----kmuy0itay5050    ba
101 0 $aeng
102   $aUS
105   $aa       001yy
200 1 $aDrug and enzyme targeting$fedited by Kenneth J. Widder, Ralph Green
210   $aOrlando [etc.]$cAcademic Press$d1985
215   $av.$cill.$d24 cm.
225 0 $aMethods in Enzymology$v149
300   $aI primi 6 v. senza titolo proprio sotto il titolo: Methods in enzymology
327   $a112: Part A ; 149: Part B
517 1 $aDrug and enzyme targeting
610 0 $aMedicinali$aEfficacia
610 0 $aEnzimi$aEfficacia
676   $a572$v23$zita
702  1$aGreen,$bRosario
702  1$aWidder,$bKenneth J.
801  0$aIT$bUNINA$gREICAT$2UNIMARC
901   $aBK
912   $a9910648900403321
952   $aBSF-MET.ENZ.-1 (112$b953$fSC1
952   $aBSF-MET.ENZ.-1 (149$b990$fSC1
952   $aA MIC 1-149$b3367/2024$fFAGBC
959   $aSC1
959   $aFAGBC
996   $aDrug and enzyme targeting$9202304
997   $aUNINA